Key words: residual SYNTAX score; SYNTAX score; unprotected left main coronary artery disease

Size: px
Start display at page:

Download "Key words: residual SYNTAX score; SYNTAX score; unprotected left main coronary artery disease"

Transcription

1 CORONARY ARTERY DISEASE Catheterization and Cardiovascular Interventions 82: (2013) Editor s Choice Objectifying the Impact of Incomplete Revascularization by Repeat Angiographic Risk Assessment With the Residual SYNTAX Score After Left Main Coronary Artery Percutaneous Coronary Intervention Davide Capodanno, 1,2 * MD, PHD, Alberto Chisari, 1 MD, Daniele Giacoppo, 1 MD, Salvatore Bonura, 1 MD, Vincenzo Lavanco, 1 MD, Piera Capranzano, 1 MD, Anna Caggegi, 1 MD, Margherita Ministeri, 1 MD, and Corrado Tamburino, 1,2 MD, PHD Objectives: We investigated the prognostic accuracy of a standardized quantification of incomplete revascularization after percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (ULMCA) named residual SYNTAX score (rss). Background: Prognostic implications of coronary lesions left untreated after ULMCA PCI are confounded by the lack of a uniform definition of incomplete revascularization. Methods: Baseline SYNTAX score (bss), rss, and the difference between bss and rss (D SS ) were assessed in predicting the risk of 2-year cardiac mortality of 400 patients undergoing ULMCA PCI. Results: The rss and bss showed comparable discrimination (rss area under the curve [AUC] 0.72, 95% confidence interval [95% CI] ; bss AUC 0.73, 95% CI ). Hosmer Lemeshow statistics were 0.60 for rss (P ) and 2.45 (P ) for bss, reflecting better calibration ability of the rss. The D SS provided the worst discrimination and calibration characteristics (AUC 0.55; 95% CI ; Hosmer Lemeshow statistic 3.13, P ). The rss was independently associated with the 2-year adjusted-risk of cardiac mortality (hazard ratio 1.07, 95% CI , P ). The risk information from both the rss and bss slightly improved the discrimination ability compared with risk information from each single risk assessment (AUC 0.74, 95% CI ) with a net reclassification improvement of 114.2% and 113.6% over rss and bss alone, respectively. Conclusions: The rss carries a prognostic value as independent predictor of 2-year cardiac mortality. Compared with a single assessment of the SYNTAX score, information coming from repeat assessment of the angiographic risk may improve the ability to discriminate and reclassify patients undergoing ULMCA PCI. VC 2013 Wiley Periodicals, Inc. Key words: residual SYNTAX score; SYNTAX score; unprotected left main coronary artery disease INTRODUCTION In patients with unprotected left main coronary artery (ULMCA) disease, percutaneous coronary intervention (PCI) is associated with nonsignificantly different rates of death and myocardial infarction (MI), a lower risk of stroke, and a higher risk of target vessel revascularization compared with coronary artery bypass grafting (CABG) [1]. One of the intuitive differences between PCI and CABG for the treatment of ULMCA concerns the ability to achieve complete anatomical revascularization, particularly in real world scenarios [2,3]. Notably, incomplete anatomical revascularization 1 Cardiovascular Department, Ferrarotto Hospital, Catania, Italy 2 ETNA Foundation, Catania, Italy Conflict of interest: Nothing to report. *Correspondence to: Davide Capodanno, MD, PHD, Cardiology Department, Ferrarotto Hospital, University of Catania, via Citelli 6, Catania, Italy. dcapodanno@gmail.com Received 24 August 2012; Revision accepted 28 August 2012 DOI /ccd Published online 8 April 2013 in Wiley Online Library (wileyonlinelibrary.com) VC 2013 Wiley Periodicals, Inc.

2 334 Capodanno et al. has been linked to mortality [4 6]. In patients with ULMCA plus additional vessels involvement, CABG offers the unique ability to address multiple coronary lesions with relatively few grafts, while protecting the distal coronary circulation if lesions proximal to the site of anastomosis continue to develop. In contrast, only target lesions are addressed during PCI and ULMCA revascularization sometimes diverts attention from other lesions, which may be perceived as technically demanding or clinically less important. Whether incomplete revascularization after ULMCA PCI carries a prognostic implication has been poorly explored. Recently, systematic characterization and quantification of residual atherosclerosis after multivessel PCI by means of the so-called residual SYNTAX score (rss) have been proposed [7]. Different from the baseline SYNTAX score (bss), a semi-quantitative angiographic model aimed at characterizing the individual coronary severity and complexity [8], the rss could be calculated after PCI to provide an objective and potentially useful quantification of incomplete revascularization. Whether this approach has a prognostic value in the setting of ULMCA PCI is currently undefined. was obtained and the final decision was made by consensus. All data were assessed for quality and entered into a dedicated computerized database. In the case of staged PCI procedures, the final planned procedure was used as the entry point for this study. Follow Up, End Points, and Definitions Information about in-hospital outcome was obtained from an electronic centralized clinical database. After discharge, all clinical follow-up data were prospectively collected by scheduled clinic evaluations or direct telephone interviews. Referring cardiologists, general practitioners, and patients were contacted whenever necessary for further information. All repeat coronary intervention and re-hospitalization data were prospectively collected during follow-up and entered into the centralized computer system of our institution or by directly contacting the hospitals where the patients were admitted or referred. Clinical events were adjudicated by an independent clinical events committee. The primary objective was the incidence of 2-year cardiac death considered as any death with a demonstrable cardiovascular cause or any death that was not clearly attributable to a non-cardiovascular cause. MATERIALS AND METHODS Patient Population We used data from the CUSTOMIZE (Appraise a CUSTOMIZEd strategy for left main revascularization) registry, a large cohort which was originally set up to investigate the effect of treatment by PCI or CABG in consecutive patients with ULMCA (defined as the presence of lesions with stenosis of at least 50% of vessel diameter) [3]. The analysis was limited to individuals undergoing PCI with complete data for calculating both the bss and the rss. The local ethics committee at each center approved the use of clinical data for this study, and all patients provided written informed consent. The authors are responsible for the completeness and accuracy of data gathering and analysis. SXscore Calculation The bss and rss were derived from the summation of the individual scorings for each lesion (defined as 50% stenosis in vessel 1.5 mm) on angiograms obtained before and after the procedure, respectively, as previously described [7 9]. All angiographic variables pertinent to bss and rss calculation were computed by two of the three experienced cardiologists, trained for SYNTAX score assessment, who were blinded to procedural data and clinical outcome. In case of disagreement, the opinion of the third observer Statistical Analysis A classification tree procedure was used to identify the optimal predictive cut off of rss in terms of cardiac mortality, as previously described [10,11]. Briefly, this method involved the segregation of different values of classification variables through a decision tree composed of progressive binary splits. Every value of each predictor variable was considered as a potential split, and the optimal split was selected based on impurity criterion (the reduction in the residual sum of squares due to a binary split of the data at that tree node). This procedure (data not shown) yielded a cutoff value of 8, consistent with Généreux et al [7]. Patients with incomplete revascularization (rss > 0) were therefore grouped into two strata of rss for analysis (rss LOW and rss HIGH ) and compared with those with complete revascularization (rss ¼ 0). For all analyses, a two-sided P < 0.05 was considered statistically significant. All data were processed using the statistical Package for Social Sciences, version 15 (SPSS, Chicago, IL). Continuous variables are presented as mean standard deviations or as median and inter-quartile range, and were compared using Student s unpaired t test or Mann-Whitney Rank Sum test, as appropriate. The normality assumption for continuous variables was evaluated by the Kolmogorov Smirnov test. Categorical variables are presented as counts and percentages and were compared with the chi-

3 Residual SYNTAX Score and LM Revascularization 335 Fig. 1. Nomograms of Models 1 and 2. In Model 1, patients at high risk (H) are those with two criteria of high risk identified by rss and bss; patients at intermediate risk (I) are those with only one criterion of high risk; patients at low risk (L) are those without any criterion of high risk. In Model 2, patients at high risk (H) are those with two criteria of high risk identified by rss and D SS ; patients at intermediate risk (I) are those with only one criterion of high risk; patients at low risk (L) are those without any criterion of high risk. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] square test when appropriate (expected frequency >5). Otherwise, the Fisher s exact test was used. The Spearman s test was used to assess the correlation between the rss and the bss. Two-year cumulative rates of cardiac mortality were estimated by the Kaplan Meier method, and the log-rank test was used to evaluate differences between groups. Cardiac mortality rates for groups characterized by different magnitude of change in the SYNTAX score over the procedure (D SS ¼ bss - rss) were also calculated. Although follow-up extended beyond 2 years in a proportion of patients at the time of data analysis, we restricted the follow-up to 2 years in all patients to account for bias introduced by incomplete follow-up. Patients lost to follow-up were considered at risk until the date of last contact, at which point they were censored. In order to adjust for a range of potential confounders, multivariate analysis of independent predictors of cardiac death was performed with a Cox proportional hazard regression model. The assumption of the proportional hazard was verified by a visual examination of the log (minus log) curves and the linearity assumption was assessed by plotting the Martingale residuals against continuous covariates. The variables considered as possible predictors included age, diabetes, left ventricular ejection fraction (LVEF), EuroSCORE, and three-vessel disease as independent control variables and rss (or any different model) as the independent study variable of interest. The selection in the final model was based on a plausible association with the primary end point or a significant P value on univariate analysis. Crude and adjusted hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were reported. The global accuracy of rss, bss, and D SS was evaluated in terms of calibration and discrimination, as previously described [8,12]. Briefly, calibration evaluates the degree of correspondence between the estimated probabilities produced by a model and the actual observation. For each score, it was measured by the Hosmer Lemeshow test. Discrimination is the probability that the score will assign higher values of risk to patients who will go on to have events compared with those who will not. It was measured by using the areas under the Receiver Operating Characteristic curve (AUC), which range from 0.50 (no discrimination) to 1.0 (perfect discrimination) and the index of separation (IoS), defined as P worst - P best, assuming P worst as the predicted P of event for a patient in the group with the highest score and P best as the predicted P of the same event for a patient in the group with the lowest score [8,12]. Net reclassification improvement (NRI) was calculated as previously described [13]. To investigate the added value of using information from both risk assessment, two further models were developed, which combined information from (i) the bss and rss (Model 1) and (ii) the rss and D SS (Model 2) (Fig. 1). This was done by fitting (i) the strata of the bss and rss or (ii) the strata of rss and D SS in a new matrix for prediction of cardiac mortality. We then computed measures of global accuracy, as described above, comparing combined information from the two new models with risk information from the bss and the rss alone. Finally, a measure of incremental prognostic value was obtained by adding into the Cox regression model for rss the bss and D SS strata, as reported in Models 1 and 2 (Fig. 1). A statistically significant increase in the global chi-square of

4 336 Capodanno et al. Fig. 2. Completeness of revascularization stratified by rss and bss. Distribution of completeness of revascularization by rss based on strata of bss. Complete revascularization was less likely to be achieved in the upper risk groups of the bss (P < 0.001). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] the model after the addition of the bss and the D SS defined the incremental prognostic value. RESULTS Patients and Baseline Characteristics Paired rss and bss metrics were available in 400 patients undergoing ULMCA PCI. The rss and the bss showed a strong positive correlation (R ¼ 0.73, P < 0.001). Patients with complete revascularization (rss ¼ 0), rss LOW (rss ¼ 1 8), and rss HIGH (rss > 8) were 48.8%, 22.8%, and 28.5%, respectively. Patients with bss LOW,bSS INTER- MEDIATE, and bss HIGH based on the historically accepted cutoffs of the SYNTAX score were 45%, 26.3%, and 28.7%, respectively. A total of 131 patients (32.8%) were differently categorized on the basis of the two scores. PCI yielded a mean decrease in SYNTAX score from bss to rss of 20 8 with a significant gradient across bss strata (15 5, 23 5, and 27 8 for patients in the bss LOW, bss INTERMEDIATE, and bss HIGH groups, respectively, P < 0.001). Figure 2 shows the level of completeness of revascularization stratified by rss and bss. Baseline demographic, clinical, and angiographic characteristics of patients stratified by completeness of revascularization are summarized in Table I. Patients with rss HIGH were older and more likely to have diabetes, lower ejection fraction, and higher EuroSCORE compared with patients with rss LOW and those with complete revascularization. Patients with rss HIGH also presented with higher angiographic complexity, reflected by higher prevalence of three-vessel disease involvement, and higher SYNTAX score at baseline. Prediction of 2-Year Cardiac Mortality The cumulative incidences of cardiac mortality at 2 years were 3.3%, 4.5%, and 19.8% in the complete revascularization, rss LOW, and rss HIGH strata, respectively (P < 0.001, Fig. 3), and 3.9%, 0.8%, and 15.9% in the bss LOW, bss INTERMEDIATE, and bss HIGH strata, respectively (P < 0.001). There were no significant differences in 2-year cardiac mortality in increasing tertiles of change in SYNTAX score from pre- to post- PCI (3.9%, 11.1%, and 6.9% for D SS-LOW, D SS-INTER- MEDIATE, D SS-HIGH, respectively, P ¼ 0.18). After adjustment for potential confounding factors, rss (HR 1.07, 95% CI , P ¼ 0.001) and LVEF (HR 0.95, 95% CI , P ¼ 0.02) were shown to be independently associated with the 2-year risk of cardiac mortality (Table II). Forcing bss in the model, rss was no longer an independent predictor of cardiac mortality, whereas LVEF was an independent predictor. The rss and the bss showed comparable discrimination (rss: AUC 0.72, 95% CI ; bss: AUC 0.73, 95% CI ), as also reflected by the similar IoS (Table III). Hosmer Lemeshow statistics were 0.60 for rss (P ¼ 0.44) and 2.45 (P ¼ 0.12) for bss, reflecting better calibration ability of the rss. The D SS provided the worst discrimination and calibration characteristics (AUC 0.55, 95% CI , Hosmer Lemeshow statistic 3.13, P ¼ 0.08) with a trivial IoS. The NRI was 2.4% for rss over bss and -58.4% for D SS over bss. Added Value of Repeat Risk Assessment Adjusted HRs and 95% CIs for different angiographic risk models are shown in Table II. When

5 Residual SYNTAX Score and LM Revascularization 337 TABLE I. Baseline Characteristics Stratified by Residual SYNTAX Score Residual SYNTAX score 0(N ¼ 195) 1 8 (N ¼ 91) >8 (N ¼ 114) P value Age, years SD Male, % 153 (79) 69 (76) 86 (75) 0.79 Risk factors, % Systemic hypertension 130 (67) 67 (74) 80 (70) 0.48 Hypercolesterolemia 103 (53) 55 (60) 65 (57) 0.46 Smoking habitus 93 (48) 36 (40) 41 (36) 0.11 Diabetes mellitus 50 (26) 30 (33) 45 (40) 0.04 Creatinine >2 mg/dl 19 (10) 4 (4) 13 (11) 0.19 Medical history, % Previous myocardial infarction 60 (31) 30 (33) 50 (44) 0.06 Peripheral artery disease 29 (15) 21 (23) 22 (19) 0.22 Previous PCI 60 (31) 24 (26) 22 (19) 0.09 Clinical presentation, % Stable angina 81 (42) 34 (37) 37 (33) 0.28 UA/NSTEMI 102 (52) 49 (54) 71 (62) 0.22 STEMI 12 (6) 8 (9) 6 (5) 0.57 LVEF, % <0.001 EuroSCORE, % <3 47 (24) 21 (23) 17 (15) (48) 38 (42) 41 (36) 0.11 >6 54 (28) 32 (35) 56 (49) Lesion location, % Ostium 76 (39) 27 (30) 33 (29) 0.12 Shaft 22 (11) 14 (15) 18 (16) 0.45 Distal 97 (50) 50 (55) 63 (55) 0.56 Extent of coronary artery disease, % Isolated ULMCA disease 28 (14) 0 (0) 0 (0) <0.001 ULMCA plus 1-vessel disease 76 (39) 20 (22) 8 (7) <0.001 ULMCA plus 2-vessel disease 42 (22) 27 (30) 26 (23) 0.31 ULMCA plus 3-vessel disease 11 (6) 17 (19) 46 (40) <0.001 SYNTAX score <0.001 LVEF ¼ left ventricular ejection fraction; NSTEMI ¼ non-st segment elevation myocardial infarction; PCI ¼ percutaneous coronary intervention; SD ¼ standard deviation; STEMI ¼ ST segment elevation myocardial infarction; UA ¼ unstable angina; ULMCA ¼ unprotected left main coronary artery. TABLE II. Adjusted HRs and 95% CIs for Different Angiographic Risk Models HR 95% LCL 95% UCL P As continuous variables a rss bss D SS As categorical variables rss bss D SS Model Model HR ¼ hazard ratio; LCL ¼ lower confidence limit; UCL ¼ higher confidence limit. Other abbreviations as in Table II. a HRs per unit increase. Fig. 3. Risk prediction of residual SYNTAX score. Kaplan Meier estimates of 2-year cardiac mortality by residual SYN- TAX score (rss) risk categories. forced in the multivariable model for statistical adjustment, both Models 1 and 2 were shown to be independent predictors of cardiac mortality at 2 years. However, although using risk information from both the rss and bss (Model 1) marginally improved the

6 338 Capodanno et al. discrimination ability compared with risk information from each single risk assessment (AUC 0.74, 95% CI ) at the price of a slightly poorer calibration (Hosmer Lemeshow statistic 1.47, P ¼ 0.23), incorporation of the change in SYNTAX score across PCI in the rss model (Model 2) yielded a worse discrimination (AUC 0.66, 95% CI ) with some improvement of the global model fit (Hosmer Lemeshow statistic 0.07, P¼0.79, Table III). In aggregate, the graphical comparison of the five models characteristics (rss, bss, D SS, Model 1, and Model 2) showed that the best balance in terms of discrimination and calibration for cardiac mortality was offered by the rss and the Model 1, with the first one displaying better calibration and the second one displaying better discrimination (Fig. 4). However, the NRI for the use of Model 1 over rss and bss were þ14.2% and þ13.6%, respectively, outlining a sensible reclassification advantage in using the combined risk TABLE III. Calibration and Discrimination Parameters HL statistic (P value) AUC (95% CI) IoS a rss 0.60 (0.44) 0.72 ( ) 0.17 bss 2.45 (0.12) 0.73 ( ) 0.15 D SS 3.13 (0.08) 0.55 ( ) 0.03 Model (0.23) 0.74 ( ) 0.21 Model (0.79) 0.66 ( ) 0.14 D SS ¼ changes in SYNTAX score from pre- to post-percutaneous coronary intervention; AUC ¼ Area under the curve; bss ¼ baseline SYN- TAX score; HL ¼ Hosmer Lemeshow; rss ¼ residual SYNTAX score. a The index of separation (IoS) is defined as P worst P best, assuming P worst as the predicted P of event for a patient in the group with the highest score and P best as the predicted P of the same event for a patient in the group with the lowest score. information over each individual score. On the other hand, the use of Model 2 was associated with an NRI of -35% over the rss and -35.6% over the bss. Consistent with the above findings, significant incremental information was obtained from the addition of bss to rss in the Cox regression model (P ¼ 0.04), while no significant incremental information was obtained from the addition of D SS (P ¼ 0.59). DISCUSSION This study adds to the growing evidence on prognostic scores in ULMCA revascularization with the following observations. First, in ULMCA patients treated with PCI, the rss calculated after the procedure is an objective measure of incomplete revascularization with prognostic significance as independent predictor of 2- year cardiac mortality. Second, compared with the bss, the rss has similar discrimination and better calibration. Third, compared with risk information from a single risk assessment, information from both the bss and the rss yields better risk classification. The prognostic implications of complete revascularization in patients with multivessel disease have been extensively documented in surgical and PCI series with mixed results [4 6,14 20]. Notably, the above studies did not address the specific subset of patients with ULMCA disease, a population with distinct prognostic implications, and expected benefits from PCI [1]. In addition, these studies lacked a uniform, standardized definition of complete revascularization and focused on different patient populations, leading to conflicting results [21]. Specifically, the incompleteness of coronary Fig. 4. Prediction accuracy of rss, bss, D SS, Model 1, and Model 2. The position of the score in the graph depends on the balance between the score calibration (assessed by the Hosmer Lemeshow statistic) and the discrimination (assessed by the area under the receiver-characteristic curve). The prognostic accuracy of each score increases from top to bottom and from left to right.

7 revascularization was established as a binary outcome (yes/no) and patients with extensive unrevascularized territories or small amounts of residual ischemic myocardium were pooled together. The advantage of better population characterization, baseline disease stratification, and residual disease quantification in patients with multivessel disease and moderate-to-high risk acute coronary syndromes enrolled in the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial has been recently emphasized, suggesting that the rss is an independent predictor of 1-year mortality, cardiac mortality, MI, and unplanned revascularization, with good discriminatory power and the potential for identifying patients with acute coronary syndromes who could benefit from further revascularization (i.e., those with rss > 8) [7]. In our study, the rss linearly correlated with the bss: the higher the bss, the higher the rss. This finding reinforces the idea that the SYNTAX score is a sensitive marker of the ability of PCI to achieve the goal of complete revascularization [3]. Interestingly, patients with high residual coronary artery disease after PCI were not only those with more complex angiographic features, such as three-vessel involvement, but also clinical features that likely discouraged or prevented the operators from attempting more complete revascularization (i.e., older age, diabetes, lower LVEF, higher EuroSCORE). This may contribute to explain why scoring systems that encompass both angiographic and clinical information are globally more accurate than scores that rely on angiographic or clinical information only, since they provide a more accurate identification of patients who are susceptible of incomplete revascularization following PCI [8,13]. Because a link between rss and cardiac mortality was demonstrated, the notion that a patient is unlikely to obtain complete revascularization from PCI (i.e., a patient with high bss) may shift the operator s treatment decision toward alternative revascularization strategies, such as CABG. Importantly, since the bss and rss carry a similar prognostic significance (bss and rss are no longer independent predictors of cardiac mortality when forced simultaneously in the multivariable model, probably due to collinearity), one could argue that calculating both scores is useless and time consuming. However, a new model integrating information from bss and rss showed to correctly reclassify about 14% of patients, thereby suggesting that repeating risk assessment in the peri-pci period improves prediction, compared with single risk assessment, and accurately reclassifies a not negligible proportion of patients into more appropriate risk categories. Repeat assessment of angiographic risk may have benefits in terms of patients and cardiologists behavior change. In fact, a clinical implication of this model is Residual SYNTAX Score and LM Revascularization 339 the identification of a sizeable cohort of patients who do not derive a significant prognostic benefit despite PCI and are therefore to be followed-up strictly. While this study demonstrates that a standardized and quantitative assessment of residual angiographic disease following ULMCA PCI may add to the prognostic information deriving from the preprocedural SYNTAX score, we were not able to observe any prognostic significance linked to the extent of revascularization by PCI. In fact, the D SS was consistently associated with weak prognostic accuracy and did not show to be predictive of cardiac mortality. In addition, a model integrating rss and D SS incorrectly reclassified about one third of patients. Although consistent with multivessel disease patients [7], the conclusions that can be drawn from these findings are limited by a number of factors. First, a minimal variation of the SYNTAX score (i.e., low D SS )includes both patients with low and high bss, with the first needing optimal medical therapy and/or few stents and the latter frequently receiving less-aggressive revascularization due to operator s choices or technical reasons. Therefore, relying on the D SS only might be puzzling. Second, the expected benefit of aggressive, extensive revascularization could be in theory counterbalanced by well-know disadvantages of PCI, especially when stents are placed on non-ischemia-producing lesions (i.e., acute kidney injury, periprocedural MI, stent thrombosis, restenosis [21,22]). Third, subsets typically represented in the highest tertiles of rss (i.e., chronic total occlusions, calcified lesions, complex bifurcations and trifurcations, small vessels) may be not ideal candidates to PCI. Finally, more patients for each bss group should be analyzed to elucidate a putative differential effect of complete revascularization across different risk strata. Overall, these findings suggest that the extent of lesions manageable by PCI alone should not be the deciding factor in selecting the best revascularization therapy for ULMCA patients. Prospectively designed studies are needed to better elucidate the role of complete revascularization and rss in patients submitted to ULMCA revascularization across different bss strata. Study Limitations This study is limited by its post-hoc nature. The CUS- TOMIZE registry is an observational study run over a long period, in which the treatment strategies for the PCI cohort might have changed over time. We cannot tell what impact these changes might have had on the results. However, time-dependent variables did not prove to be necessary to improve the accuracy of any model. Second, the results of this study may have varied if the bss and rss were assessed by core lab technicians with the aid of quantitative coronary analysis. Third, risk models such as

8 340 Capodanno et al. the SYNTAX score rely on the assumption that angiographic complete revascularization is always the goal of intervention, which, in reality, is often not achievable through either PCI or CABG. Therefore, both the bss and rss may theoretically be improved upon by knowledge of ischemia or viability. Finally, statistical adjustment was attempted by means of a parsimonious multivariable model with good discrimination and calibration abilities. However, the impact of unidentified confounders cannot be entirely ruled out. CONCLUSIONS A quantitative assessment of the incompleteness of revascularization following ULMCA PCI by means of the rss carries a prognostic significance as independent predictor of 2-year cardiac mortality. Individuals with high estimated risk both pre- and post-ulmca PCI have higher risk of cardiac mortality than those who remain in the lowest risk category at both assessment. Compared with a single assessment of the SYNTAX score, information coming from repeat assessment of the angiographic risk may improve the ability to correctly reclassify patients undergoing ULMCA PCI. REFERENCES 1. Capodanno D, Stone GW, Morice MC, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data. J Am Coll Cardiol 2011;58: Chieffo A, Meliga E, Latib A, et al. Drug eluting stent for left main coronary artery disease: the DELTA Registry a multicenter registry evaluating PCI vs. CABG for left main treatment. JACC Cardiovasc Interv 2012;5: Capodanno D, Capranzano P, Di Salvo ME, et al. Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft. JACC Cardiovasc Interv 2009;2: Kim YH, Park DW, Lee JY, et al. Impact of angiographic complete revascularization after drug-eluting stent implantation or coronary artery bypass graft surgery for multivessel coronary artery disease. Circulation 2011;123: Tamburino C, Angiolillo DJ, Capranzano P, et al. Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drugeluting stents. Catheter Cardiovasc Interv 2008;72: Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv 2009;2: Généreux P, Palmerini T, Caixeta A, et al. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: The Residual SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery) score. J Am Coll Cardiol 2012;59: Capodanno D, Tamburino C. Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: use, pitfalls, and new directions. Am Heart J 2011;161: Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005;1: Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol 2007;99: Capodanno D, Di Salvo ME, Cincotta G, et al. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv 2009;2: Capodanno D, Caggegi A, Miano M, et al. Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization. JACC Cardiovasc Interv 2011;4: Capodanno D, Miano M, Cincotta G, et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 2010;159: Kleisli T, Cheng W, Jacobs MJ, et al. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2005;129: Vander Salm TJ, Kip KE, Jones RH, et al. What constitutes optimal surgical revascularization? Answers from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 2002;39: Van den Brand MJ, Rensing BJ, Morel MA, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;19: Head SJ, Mack MJ, Holmes DR Jr., et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg 2012;41: Aggarwal V, Rajpathak S, Singh M, et al. Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. EuroIntervention 2012;7: Ijsselmuiden AJ, Ezechiels J, Westendorp IC, et al. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. Am Heart J 2004;148: De Bruyne B. Multivessel disease: from reasonably incomplete to functionally complete revascularization. Circulation 2012;125: Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105: Holmes DR Jr, Kereiakes DJ, Garg S, et al. Stent thrombosis. J Am Coll Cardiol 2010;56:

Davide Capodanno, MD; Maria Elena Di Salvo, MD; Glauco Cincotta, MD; Marco Miano, MD; Claudia Tamburino, MD; Corrado Tamburino, MD, PhD, FESC, FSCAI

Davide Capodanno, MD; Maria Elena Di Salvo, MD; Glauco Cincotta, MD; Marco Miano, MD; Claudia Tamburino, MD; Corrado Tamburino, MD, PhD, FESC, FSCAI Usefulness of the SYNTAX Score for Predicting Clinical Outcome After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease Davide Capodanno, MD; Maria Elena Di Salvo, MD;

More information

Left Main and Bifurcation Summit I. Lessons from European LM Studies

Left Main and Bifurcation Summit I. Lessons from European LM Studies Left Main and Bifurcation Summit I Apr 29 8.56-9.09 Lessons from European LM Studies Alaide Chieffo, MD S. Raffaele Hospital, Milan, Italy Nothing to disclose regarding this presentation Lesion Location

More information

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017 Igor F. Palacios, MD Director of Interventional Cardiology Professor of Medicine Massachusetts

More information

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy

Unprotected Left Main Stenting: Patient Selection and Recent Experience. Alaide Chieffo. S. Raffaele Hospital, Milan, Italy Unprotected Left Main Stenting: Patient Selection and Recent Experience Alaide Chieffo S. Raffaele Hospital, Milan, Italy Class IIa (Level B) AHA/ACC 2005 Guidelines Left Main CAD The use of PCI for pts

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

The SYNTAX-LE MANS Study

The SYNTAX-LE MANS Study The SYNTAX-LE MANS Study Synergy Between PCI with TAXUS Express and Cardiac Surgery: Late (15-month) Left Main Angiographic Substudy A. Pieter Kappetein, MD, PhD Erasmus MC, Rotterdam, NL SYNTAX-LE MANS

More information

Rationale for Percutaneous Revascularization ESC 2011

Rationale for Percutaneous Revascularization ESC 2011 Rationale for Percutaneous Revascularization Marie Claude Morice, Massy FR MD, FESC, FACC ESC 2011 Paris Villepinte - 27-31 August, 2011 Massy, France Potential conflicts of interest I have the following

More information

SYNTAX score before decision making! Corrado Tamburino, MD, PhD

SYNTAX score before decision making! Corrado Tamburino, MD, PhD SYNTAX score in left main - Tamburino TCT Asia Pacific Seoul, 27 April 2011 Slide 1 SYNTAX score before decision making! Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate

More information

Important LM bifurcation studies update

Important LM bifurcation studies update 8 th European Bifurcation Club 12-13 October 2012 - Barcelona Important LM bifurcation studies update I Sheiban E-mail: isheiban@yahoo.com Unprotected LM Percutaneous Revascularization What is important

More information

Journal of the American College of Cardiology Vol. 57, No. 21, by the American College of Cardiology Foundation ISSN /$36.

Journal of the American College of Cardiology Vol. 57, No. 21, by the American College of Cardiology Foundation ISSN /$36. Journal of the American College of Cardiology Vol. 57, No. 21, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.01.033

More information

Perspective of LM stenting with Current registry and Randomized Clinical Data

Perspective of LM stenting with Current registry and Randomized Clinical Data Asian Pacific TCT Perspective of LM stenting with Current registry and Randomized Clinical Data Patrick W. Serruys MD PhD Yoshinobu Onuma MD Seung-Jung Park MD, PhD 14:48-15:00, 2009 Symposium Arena, Level

More information

Upgrade of Recommendation

Upgrade of Recommendation Challenges in LM PCI Decision-making process for stenting Young-Hak Kim, MD, PhD, Heart Institute, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea Upgrade of Recommendation for

More information

Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery

Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected left main coronary artery Journal of Geriatric Cardiology (2017) 14: 254 260 2017 JGC All rights reserved; www.jgc301.com Research Article Open Access Long-term outcomes of PCI vs. CABG for ostial/midshaft lesions in unprotected

More information

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER

When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER When should we indisputably perform CABG? Quand faut-il indiscutablement opérer? Dr Hakim BENAMER ICPS, Massy ICV-GVM La Roseraie, Aubervilliers Hôpital FOCH, Suresnes Disclosure Statement of Financial

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD

Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD Mise à Jour sur le traitement du Pluritronculaire Philippe Généreux, MD Columbia University Medical Center and The Cardiovascular Research Foundation, New York, USA Hôpital du Sacré-Coeur de Montréal,

More information

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease

Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang

More information

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention

Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention Original Article Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention

Quantification and Impact of Untreated Coronary Artery Disease After Percutaneous Coronary Intervention Journal of the American College of Cardiology Vol. 59, No. 24, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2012.03.010

More information

INTRODUCTION. Key Words:

INTRODUCTION. Key Words: Original Article??? Acta Cardiol Sin 2012;28:118 128 Cardiac Surgery Global Risk Classification Predicts the Clinical Outcomes of Patients with Significant Left Main Coronary Artery Disease Undergoing

More information

PROMUS Element Experience In AMC

PROMUS Element Experience In AMC Promus Element Luncheon Symposium: PROMUS Element Experience In AMC Jung-Min Ahn, MD. University of Ulsan College of Medicine, Heart Institute, Asan Medical Center, Seoul, Korea PROMUS Element Clinical

More information

Controversies in Cardiac Surgery

Controversies in Cardiac Surgery Controversies in Cardiac Surgery 3 years after SYNTAX : Percutaneous Coronary Intervention for Multivessel / Left main stem Coronary artery disease Pro ESC Congress 2010, 28 August 1 September Stockholm

More information

Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality

Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality Shun Watanabe, MD, Tatsuhiko Komiya, MD, Genichi Sakaguchi, MD, PhD, and Takeshi Shimamoto, MD, PhD Department

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

PCI for LMCA lesions A Review of latest guidelines and relevant evidence

PCI for LMCA lesions A Review of latest guidelines and relevant evidence HCS Working Group Seminars Met Hotel, Thursday 14 th February 2013 PCI for LMCA lesions A Review of latest guidelines and relevant evidence Vassilis Spanos Interventional Cardiologist, As. Director 3 rd

More information

PCI vs. CABG From BARI to Syntax, Is The Game Over?

PCI vs. CABG From BARI to Syntax, Is The Game Over? PCI vs. CABG From BARI to Syntax, Is The Game Over? Seung-Jung Park, MD, PhD Professor of Medicine, University of Ulsan College of Medicine Asan Medical Center, Seoul, Korea PCI vs CABG Multi-Vessel Disease

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Kurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report

Kurdistan Technique for the Treatment of Unprotected Trifurcation Left Main Stem Coronary Artery Lesion: Case Report World Journal of Cardiovascular Diseases, 2014, 4, 483-491 Published Online August 2014 in SciRes. http://www.scirp.org/journal/wjcd http://dx.doi.org/10.4236/wjcd.2014.49058 Kurdistan Technique for the

More information

New Generation Drug- Eluting Stent in Korea

New Generation Drug- Eluting Stent in Korea New Generation Drug- Eluting Stent in Korea Young-Hak Kim, MD, PhD Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose To briefly introduce the

More information

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX Boston Scientific, Inc.- Syntax Trial Steering Committee Member- travel expenses paid by trial sponsor Maquet, Inc.- unpaid

More information

Myocardial revascularisation in multivessel disease: The value of risks scores

Myocardial revascularisation in multivessel disease: The value of risks scores Myocardial revascularisation in multivessel disease: The value of risks scores ESC 2012 Marie Claude Morice, Darren Mylotte, Institut cardiovasculaire Paria Sud, Massy,France Declaration of conflict of

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention

Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing percutaneous coronary intervention Journal of Geriatric Cardiology (2016) 13: 733 739 2016 JGC All rights reserved; www.jgc301.com Research Article Open Access Predictive value of SYNTAX score II for clinical outcomes in octogenarian undergoing

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents

Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Komplexe Koronarintervention heute: Von Syntax zu bioresorbierbaren Stents Prof. Dr. med. Julinda Mehilli Medizinische Klinik und Poliklinik I Klinikum der Universität München Campus Großhadern Key Factors

More information

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France PCI for Left Main Coronary Artery Stenosis Jean Fajadet Clinique Pasteur, Toulouse, France Athens, October 19, 2018 Left Main Coronary Artery Disease Significant unprotected left main coronary artery disease

More information

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil COMMENT DEFINIR UN PLURITRONCULAIRE VISION ANGIOGRAHIQUE DU PLURITRONCULAIRE Didier Carrié CHU Toulouse Rangueil Congrès GRCI 03 Décembre 2010 Pôle Cardiovasculaire et Métabolique Avec quel œil je regarde

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Importance of the third arterial graft in multiple arterial grafting strategies

Importance of the third arterial graft in multiple arterial grafting strategies Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center

Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at a Tertiary Medical Center Aging Research Volume 2013, Article ID 471026, 4 pages http://dx.doi.org/10.1155/2013/471026 Clinical Study Age Differences in Long Term Outcomes of Coronary Patients Treated with Drug Eluting Stents at

More information

Statistical analysis plan

Statistical analysis plan Statistical analysis plan Prepared and approved for the BIOMArCS 2 glucose trial by Prof. Dr. Eric Boersma Dr. Victor Umans Dr. Jan Hein Cornel Maarten de Mulder Statistical analysis plan - BIOMArCS 2

More information

The MAIN-COMPARE Registry

The MAIN-COMPARE Registry Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized

More information

Left Main Intervention: Will it become standard of care?

Left Main Intervention: Will it become standard of care? Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,

More information

Journal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 47, No. 7, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 47, No. 7, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.05.102

More information

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion Hyeon-Cheol Gwon Cardiac and Vascular Center Samsung Medical Center Sungkyunkwan University School of Medicine Dr. Hyeon-Cheol

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

1. Whether the risks of stent thrombosis (ST) and major adverse cardiovascular and cerebrovascular events (MACCE) differ from BMS and DES

1. Whether the risks of stent thrombosis (ST) and major adverse cardiovascular and cerebrovascular events (MACCE) differ from BMS and DES 1 Comparison of Ischemic and Bleeding Events After Drug- Eluting Stents or Bare Metal Stents in Subjects Receiving Dual Antiplatelet Therapy: Results from the Randomized Dual Antiplatelet Therapy (DAPT)

More information

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016

Controversies in Coronary Revascularization. Atlanta CCU April 15, 2016 Controversies in Coronary Revascularization Atlanta CCU April 15, 2016 Habib Samady MD FACC FSCAI Professor of Medicine Director, Interventional Cardiology, Emory University Director, Cardiac Catheterization

More information

Left Main PCI vs. CABG: Real World

Left Main PCI vs. CABG: Real World Management of Patients with Stable CAD Left Main PCI vs. CABG: Real World Marco Roffi, MD, FESC University Hospital Geneva, Switzerland SYNTAX-LMT The SYNTAX trial included a pre-specified subgroup of

More information

Coronary Revascularization for Patients with Severe Coronary Artery Disease: An Overview of Current Evidence and Treatment Strategies

Coronary Revascularization for Patients with Severe Coronary Artery Disease: An Overview of Current Evidence and Treatment Strategies Review J Jpn Coron Assoc 2015; 21: 267-271 Coronary Revascularization for Patients with Severe Coronary Artery Disease: An Overview of Current Evidence and Treatment Strategies Hiroki Shiomi, Takeshi Kimura

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study

The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study Five-Year Results in the French Subset René Koning, MD On behalf of the SYNTAX investigators Three-year

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions

A Risk Score to Predict In-Hospital Mortality for Percutaneous Coronary Interventions Journal of the American College of Cardiology Vol. 47, No. 3, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.09.071

More information

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic

Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Gender-Based Outcomes in Percutaneous Coronary Intervention with Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) J. D. Abbott, et al. Am J Cardiol (2007) 99;626-31

More information

Cardiology Department Coimbra Hospital and Medical School Portugal

Cardiology Department Coimbra Hospital and Medical School Portugal Quantitative troponin elevation provide incremental prognostic value beyond comprehensive risk stratification in patients with acute coronary syndromes. Rui Baptista, Elisabete Jorge, Hélia Martins, Fátima

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study

Coronary Artery Stenosis. Insight from MAIN-COMPARE Study PCI for Unprotected Left Main Coronary Artery Stenosis Insight from MAIN-COMPARE Study Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Asan Medical Center Current Practice

More information

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center 2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium Does Lt Late Cth Catch up Exist Eiti in DES? : Quantitative Coronary Angiography Analysis Kyung Woo Park, MD Cardiovascular

More information

Diabetic Patients: Current Evidence of Revascularization

Diabetic Patients: Current Evidence of Revascularization Diabetic Patients: Current Evidence of Revascularization Alexandra J. Lansky, MD Yale University School of Medicine University College of London The Problem with Diabetic Patients Endothelial dysfunction

More information

Quality of Life After Everolimus- Eluting Stents or Bypass Surgery for Treatment of Left Main Coronary Artery Disease:

Quality of Life After Everolimus- Eluting Stents or Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Quality of Life After Everolimus- Eluting Stents or Bypass Surgery for Treatment of Left Main Coronary Artery Disease: Results from the EXCEL Trial Suzanne J. Baron MD MSC on behalf of the EXCEL Investigators

More information

Long-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting

Long-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting Long-Term Mortality of Coronary Artery Bypass Grafting and Bare-Metal Stenting Chuntao Wu, MD, PhD, Songyang Zhao, MS, Andrew S. Wechsler, MD, Stephen Lahey, MD, Gary Walford, MD, Alfred T. Culliford,

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation? Keun-Ho Park, Myung Ho Jeong, Min Goo Lee, Jum Suk Ko,

More information

Clinical Investigations

Clinical Investigations Clinical Investigations Clinical Outcomes for Single Stent and Multiple Stents in Contemporary Practice Qiao Shu Bin, MD; Liu Sheng Wen, MD; Xu Bo, BS; Chen Jue, MD; Liu Hai Bo, MD; Yang Yue Jin, MD; Chen

More information

Clinical Considerations for CTO

Clinical Considerations for CTO 38 RCTs Clinical Considerations for CTO 18,000 pts Revascularization Whom to treat, Who derives benefit and What can we achieve? David E. Kandzari, MD FACC, FSCAI Director, Interventional Cardiology Research

More information

Δημήτριος Αγγοσράς, FETCS

Δημήτριος Αγγοσράς, FETCS ΣΕΜΙΝΑΡΙΟ ΟΜΑΔΩΝ ΕΡΓΑΣΙΑΣ Δημήτριος Αγγοσράς, FETCS Επίκοσρος Καθηγηηής Καρδιοτειροσργικής Ιαηρική Πανεπιζηημίοσ Αθηνών Πανεπιζηημιακό Γενικό Νοζοκομείο Αηηικόν Randomized Controlled Trials (RCTs) Why

More information

Management of cardiovascular disease - coronary interventions -

Management of cardiovascular disease - coronary interventions - Master Classes in Preventive Cardiology I Management of diabetes in patients with CVD European Heart House Management of cardiovascular disease - coronary interventions - Francesco Cosentino MD, PhD, FESC

More information

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions

Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large coronary vessel lesions Journal of Geriatric Cardiology (2017) 14: 35 41 2017 JGC All rights reserved; www.jgc301.com Research Article Open Access Nine-year clinical outcomes of drug-eluting stents vs. bare metal stents for large

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011 Prof. Dr. Volkmar Falk Klinik für Herz- und Gefäßchirurgie, Universitätsspital Zürich, Schweiz In 2004 headlines were

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

R&M Solutions

R&M Solutions PCI with DES versus CABG & syntax score Dr. Mohamed Sobhy, MD, FACC, FESC Professor of Cardiology, Alexandria University, Egypt Head of Cardiology Department President of Egyptian Society of Cardiology

More information

Bern-Rotterdam Cohort Study

Bern-Rotterdam Cohort Study Bern-Rotterdam Cohort Study Newer generation everolimus-eluting stents eliminate the risk of very late stent thrombosis compared with early generation sirolimus-eluting and paclitaxel-eluting stents Lorenz

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Incidence and Treatment for LM In-Stent

Incidence and Treatment for LM In-Stent Incidence and Treatment for LM In-Stent Restenosis Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular Department, Director Cardiology

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

STEMI AND MULTIVESSEL CORONARY DISEASE

STEMI AND MULTIVESSEL CORONARY DISEASE STEMI AND MULTIVESSEL CORONARY DISEASE ΤΣΙΑΦΟΥΤΗΣ Ν. ΙΩΑΝΝΗΣ ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ Α ΚΑΡΔΙΟΛΟΓΙΚΗ ΝΟΣ ΕΡΥΘΡΟΥ ΣΤΑΥΡΟΥ IRA 30-50% of STEMI patients have additional stenoses other than the infarct related

More information

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France

Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Left Main Disease: what is left to surgery? Prof. Jacques Monségu CardioVascular Institute Grenoble, France Background on LM stenosis 5% of patients undergoing angiography Of the myocardium 80% Bifurcation

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis

More information

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts

More information

RCA Disease and Unprotected LM Stenting

RCA Disease and Unprotected LM Stenting Original Article RCA Disease and Unprotected LM Stenting Acta Cardiol Sin 2011;27:14 20 Coronary Heart Disease The Clinical Significance of Right Coronary Artery Stenosis on the Prognosis of Patients with

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Conflict of Interest Institutional research grants and speaker s fee from St. Jude Medical and Boston Scientic to Cardiovascular

More information

Management of High-Risk Coronary Artery Disease

Management of High-Risk Coronary Artery Disease Management of High-Risk Coronary Artery Disease Jeffrey J. Popma, MD Director, Interventional Cardiology Clinical Services Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard Medical

More information

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,

More information

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index

SUPPLEMENTAL MATERIAL. Supplemental Methods. Duke CAD Index SUPPLEMENTAL MATERIAL Supplemental Methods Duke CAD Index The Duke CAD index, originally developed by David F. Kong, is an angiographic score that hierarchically assigns prognostic weights (0-100) based

More information

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands

COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands COMPARE Trial Elvin Kedhi Maasstad Ziekenhuis Rotterdam The Netherlands TCTAP 2010 Seoul, Korea Disclosures Research Foundation of the Cardiology Department has received unrestricted research grants from:

More information

Journal of the American College of Cardiology Vol. 47, No. 8, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 47, No. 8, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 47, No. 8, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.11.066

More information

Journal of the American College of Cardiology Vol. 42, No. 10, by the American College of Cardiology Foundation ISSN /03/$30.

Journal of the American College of Cardiology Vol. 42, No. 10, by the American College of Cardiology Foundation ISSN /03/$30. Journal of the American College of Cardiology Vol. 42, No. 10, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2003.05.007

More information

Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology

Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology REVIEW Korean J Intern Med 2018;33:851-859 Percutaneous coronary intervention in patients with multi-vessel coronary artery disease: a focus on physiology Yun-Kyeong Cho and Chang-Wook Nam Division of

More information

IVUS vs FFR Debate: IVUS-Guided PCI

IVUS vs FFR Debate: IVUS-Guided PCI IVUS vs FFR Debate: IVUS-Guided PCI Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Disclosure Statement of Financial Interest Within the past 12 months, I have had a financial interest/arrangement

More information